We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclaimer
- Importance of Pharmacovigilance (PV)
- Drug research and development
- WHO global patient safety action plan 2021–2030
- Why patients?
- Objectives of World Patient Safety Day 2023
- Risk management in post marketing
- CIOMS position
- Benefits of patient-centric PV
- Stakeholders
- The value of patients reporting AEs directly
- Educational campaigns: citizens need to be involved
- How is patient engagement increased?
- Engaging patients when communicating risks
- Case study 1
- Case study 2: Gravitate Health
- Case study 3: WEB-RADR 2
- Final considerations for a journey at its beginning (1)
- Final considerations for a journey at its beginning (2)
- Summary
Topics Covered
- Importance of pharmacovigilance (PV)
- The drug discovery process
- WHO global patient safety action plan, 2021 to 2030
- Elevating a patient’s voice and patient engagement in healthcare
- Risk management in post marketing
- Reporting Adverse Drug Reactions (ADRs)
Links
Categories:
External Links
Talk Citation
Pareschi, R.E. (2025, February 27). Patient centricity in pharmacovigilance: how we can elevate a patient’s voice [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 10, 2025, from https://doi.org/10.69645/VGWZ7117.Export Citation (RIS)
Publication History
- Published on February 27, 2025
Financial Disclosures
- Dr.Pareschi is an employee of Roche Pharma Brazil, he has stocks from Merck & Co (known as MSD outside US and Canada) and also from Roche.
Patient centricity in pharmacovigilance: how we can elevate a patient’s voice
Published on February 27, 2025
23 min
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Raphael Pareschi
pharmacists and biochemist
by training and working for
17 years in pharma industry.
Especially in quality
pharmacovigilance
and patient safety.
My presentation is about
how to put the
patient at the center
of pharmacovigilance
systems or PV systems.
Especially how the
industry can work with
other stakeholders to elevate
the patient's voice in
the healthcare
system and emphasize
patient and family
engagement to improve
patient safety across
the product life cycle.
0:39
Medicines and vaccines have
revolutionized the prevention
and treatment of diseases
offering immense
benefits to our health.
However, alongside
these benefits,
they can be also side effects
some of which maybe
undesirable or unexpected.
This is where pharmacovigilance
comes into play.
Pharmacovigilance is the science
dedicated to
detecting assessing,
understanding and
prevailing adverse effects
and any other problems related
to medicine and vaccines.
Before any medicine or vaccine
is authorized for use.
It undergoes rigorous
testing for safety
and efficacy via
clinical trials.
These trials are conducted on
a relatively small select group
of individuals over
a short period.
Despite this rigorous testing,
certain side effects
may only become
apparent once these
products are used by
a diverse larger population
including individuals
with other concurrent diseases
and over extended periods.
They're stating and managing
these risks via
pharmacovigilance is
crucial for ensuring
the continued safety
and efficacy of
medicinal products.
Hide